// App-Quantinova.ai

: Bone Marrow Biopsy Impacts Response Assessment in a Minority of Patients with Follicular Lymphoma and Diffuse Large B-Cell Lymphoma Treated with Immunochemotherapy: Results from the Randomized Phase III GALLIUM and GOYA Trials

Researchers

Presenter

  • Sarah C. Rutherford

Principal Investigators

  • Michael Herold

  • Wolfgang Hiddemann

  • Lale Kostakoglu

  • Robert Marcus

  • Maurizio Martelli

  • Laurie H Sehn

  • Marek Trnen

  • Judith Trotman

  • Umberto Vitolo

  • Tina Nielsen

  • Federico Mattiello

  • Deniz Sahin

  • Gila Sellam

  • Peter Martin

Medical Centers

  • Division of Hematology & Medical Oncology, Weill Cornell Medical College, New York, NY

  • HELIOS‐Klinikum, Erfurt, Germany

  • Department of Neurosurgery, Ludwig-Maximilians University Munich, Munich, Germany

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • Kings College London, London, United Kingdom

  • Sapienza University, Rome, Italy

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • 1st Medical Department, Charles University General Hospital, Prague, Czech Republic

  • Concord Repatriation General Hospital, University of Sydney, Sydney, Australia

  • Department of Rheumatology, Azienda Ospedaliera Universitaria Citta della Salute e della Scienza di Torino, Turin, Italy,

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Division of Hematology & Medical Oncology, Weill Cornell Medical College & New York-Presbyterian Hospital, New York, NY

Locations

  • United States

  • Germany

  • United Kingdom

  • Italy

  • Canada

  • Czech Republic

  • Australia

  • Switzerland

Companies

  • F. Hoffmann-La Roche

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Follicular lymphoma

  • B cell lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

Phase

  • III

Study Id's

  • NCT01332968

  • NCT01287741

Sponsors

  • N/A

Result

  • N/A